ADMA BIOLOGICS, INC. (ADMA) Shareholders’ equity 2016–2025
ADMA BIOLOGICS, INC. (ADMA) shareholders’ equity at each fiscal year-end, per SEC filings.
$477.3MFY2025 · since FY2016: -$4.5M → $477.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $477.3M | +36.8% |
| FY2024 | $349.0M | +158.1% |
| FY2023 | $135.2M | -11.0% |
| FY2022 | $152.0M | +7.7% |
| FY2021 | $141.2M | +60.0% |
| FY2020 | $88.2M | +236.9% |
| FY2019 | $26.2M | +32.5% |
| FY2018 | $19.8M | -51.0% |
| FY2017 | $40.3M | +1004.9% |
| FY2016 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice